iBio’s Comprehensive Approach to Antibody-Based Therapeutics
June 12, 2024
Learn More
Media & Events
iBio, AstralBio Collab on Obesity Drug Discovery
April 8, 2024
iBio fast-tracking discovery for hard-to-drug targets with precision antibody therapeutics powered by AI and machine learning
February 6, 2024
Moving beyond buzzwords: When will a rising AI tide lift all Big Pharma boats?
January 19, 2024
iBio’s chief reveals strategy behind AI-driven bispecific antibody discovery plans
June 14, 2023
Biotech firm iBio (NYSEA:IBIO) has incorporated EngageTx, a machine learning-driven technology, into its development roadmap.